Publication | Closed Access

5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure–activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors

Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug DesignMechanism Of ActionPharmacological Agent7-Substituted Heteroaryl AnalogsPharmacotherapyStructure–activity RelationshipsChemical BiologyPharmacologyMolecular ModelingPharmaceutical ChemistryDrug Discovery